Clinical Trial Update: Inhibition of Late Sodium Current (INa) to Prevent Coronary MICROvascular Dysfunction in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Disease: INaMICRON Study [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial (INaMICRON) investigating inhibition of the late sodium current to prevent coronary microvascular dysfunction in patients with ST-ele…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Snippet

Sponsor: Federico II University | Conditions: STEMI (ST Elevation MI) | Phase 2, Phase 3 | Status: RECRUITING